Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ZBH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsZimmer Biomet shareholders approve all management proposals at 2026 annual meeting
Filed May 27, 2026 · Period ending May 22, 2026 · ~1 min read
Key Changes
-
low
All 10 director nominees elected for one-year terms ending at 2027 annual meeting, maintaining current board composition.
Item 5.07 verify on EDGAR → -
low
Shareholders ratified PricewaterhouseCoopers LLP as independent auditor for 2026, continuing existing audit relationship.
Item 5.07 verify on EDGAR → -
low
Executive compensation approved on advisory basis, indicating shareholder support for current pay practices.
Item 5.07 verify on EDGAR → -
low
Shareholder proposal requiring independent board chairman rejected, allowing current leadership structure to continue.
Item 5.07 verify on EDGAR →
Summary
Zimmer Biomet held its annual shareholder meeting on May 22, 2026, with all management-recommended proposals passing as expected. The company's full slate of 10 directors was re-elected, the existing auditor relationship was ratified, and executive compensation received advisory approval from shareholders. The only contested item was a shareholder proposal calling for an independent board chairman, which failed.
For retail investors, this is a routine procedural filing with no material business impact. The voting results suggest general shareholder satisfaction with current governance and management. The rejection of the independent chairman proposal means the existing board leadership structure remains unchanged.
Watch for the company's proxy statement filing later this year, which will detail specific vote counts and provide insight into the level of shareholder support for each proposal. Any significant dissent on executive pay or director elections could signal emerging governance concerns.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Zimmer Biomet held its 2026 annual shareholder meeting, electing 10 directors, ratifying auditor, approving executive pay, and rejecting independent chair proposal.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 22, 2026. Shareholders took the following actions:
• elected ten (10) directors for one-year terms ending at the 2027 annual meeting of shareholders (Proposal 1);
• ratified the Audit Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026 (Proposal 2);
• approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement (Proposal 3); and
• rejected a shareholder proposal on Independent Board Chairman (Proposal 4).
The company held its annual shareholder meeting on May 22, 2026. Shareholders elected all ten director nominees for one-year terms, ratified PricewaterhouseCoopers as the independent auditor for 2026, approved executive compensation on an advisory basis, and voted down a shareholder proposal requiring an independent board chairman. All routine governance matters passed as recommended by management except the shareholder proposal.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify